<DOC>
	<DOCNO>NCT00876148</DOCNO>
	<brief_summary>The purpose study evaluate risk hepatitis B reactivation patient undergo allografting .</brief_summary>
	<brief_title>Risk Hepatitis B Virus Reactivation Patients Undergoing Allografting</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<criteria>All patient undergo allograft hematological malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Incidence hepatitis B allografting</keyword>
	<keyword>Risk hepatitis B reactivation</keyword>
	<keyword>Lamivudine prophylaxis</keyword>
</DOC>